Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials.
Saved in:
| Title: | Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials. |
|---|---|
| Authors: | Colombel JF; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Danese S; Department of Gastroenterology, IRCCS San Raffaele Hospital and Vita-Salute University, Milan, Italy., Schreiber S; Department of Medicine I, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany., Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Yarur AJ; F. Widjaja Inflammatory Bowel Disease Institute, Cedars Sinai Medical Center, Los Angeles, California, USA., Kang A; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Kim DH; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Lee YN; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Hanauer SB; Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. |
| Source: | United European gastroenterology journal [United European Gastroenterol J] 2026 Apr; Vol. 14 (3), pp. e70205. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101606807 Publication Model: Print Cited Medium: Internet ISSN: 2050-6414 (Electronic) Linking ISSN: 20506406 NLM ISO Abbreviation: United European Gastroenterol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41986154 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Colombel+JF%22">Colombel JF</searchLink>; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Danese+S%22">Danese S</searchLink>; Department of Gastroenterology, IRCCS San Raffaele Hospital and Vita-Salute University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Schreiber+S%22">Schreiber S</searchLink>; Department of Medicine I, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Sands+BE%22">Sands BE</searchLink>; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Yarur+AJ%22">Yarur AJ</searchLink>; F. Widjaja Inflammatory Bowel Disease Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Kang+A%22">Kang A</searchLink>; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DH%22">Kim DH</searchLink>; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+YN%22">Lee YN</searchLink>; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hanauer+SB%22">Hanauer SB</searchLink>; Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101606807%22">United European gastroenterology journal</searchLink> [United European Gastroenterol J] 2026 Apr; Vol. 14 (3), pp. e70205. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101606807 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-6414 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220506406%22">20506406 </searchLink><i>NLM ISO Abbreviation: </i>United European Gastroenterol J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41986154 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ueg2.70205 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70205 Titles: – TitleFull: Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Colombel JF – PersonEntity: Name: NameFull: Danese S – PersonEntity: Name: NameFull: Schreiber S – PersonEntity: Name: NameFull: Sands BE – PersonEntity: Name: NameFull: Yarur AJ – PersonEntity: Name: NameFull: Kang A – PersonEntity: Name: NameFull: Kim DH – PersonEntity: Name: NameFull: Lee YN – PersonEntity: Name: NameFull: Hanauer SB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2050-6414 Numbering: – Type: volume Value: 14 – Type: issue Value: 3 Titles: – TitleFull: United European gastroenterology journal Type: main |
| ResultId | 1 |
